The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
A Simple Solution to Embolism in Atrial Fibrillation
February 2nd 2015For patients with non-valvular atrial fibrillation, preventing stroke using anti-coagulation medication is the standard of care. This study looked at using a device that closes off the left atrial appendage of the heart to determine if it too would lower the risk of stroke.
Vegetarian Diet Reverses Coronary Artery Disease
February 2nd 2015This study was a prospective cohort of 198 self-selected, adult patients with documented coronary artery disease, cerebrovascular disease, carotid artery disease, or peripheral arterial disease who followed a strict, plant-based dietary intervention in addition to standard medical therapy. The study examined compliance with diet as well as adverse cardiovascular events in both adherent and nonadherent patients.
60-Year-Old Man With Skipped Heartbeat, Shortness of Breath and Light-headedness
February 2nd 2015A 60 year-old man presents with complaints of a skipped heartbeat, shortness of breath and some light-headedness while sitting. When he is active, he has none of these symptoms. He is able to walk, climb stairs and even exercise on his elliptical without symptoms.
Comparing Varenicline with and Without Nicotine Replacement Therapy for Smoking Cessation
February 2nd 2015While various behavioral and pharmacologic agents have proven to be effective and safe for continued smoking cessation, a combination of varenicline and nicotine replacement (NRT) with transdermal patches has not been shown definitively to be more efficacious than varenicline alone. In the framework of a randomized clinical trial (RCT), the present study evaluates whether a combination of varenicline with NRT improved smoking cessation rates and abstinence duration compared with varenicline alone.
Shocks Reduced in Improved Implantable Defibrillator
Implantable cardioverter-defibrillators (ICDs) have prevented cardiac arrests and deaths, but they carry a risk of giving patients shocks when they don't need them. That inappropriate shock rate has been estimated as occurring in 10 to 20% of patients with the devices, causing unnecessary hospital admissions, and a negative impact on patients' quality of life. They are also associated with increased morbidity and mortality for some patients. But in a study in Heart Rhythm Angelo Auricchio, MD, PhD, and colleagues report on technological improvements in a Medtronic device that has reduced those shocks to 1.5% with a dual/triple chamber defibrillator and 2.5% for a single chamber ICD after one year.
Steroid Therapy: Increasing Risk of Blood Clots 5-fold in IBD Patients
Corticosteroid (steroid) is associated with an approximately 5-fold increase of venous thromboembolism in patients suffering from inflammatory bowel disease (IBD), according to a new study published in Clinical Gastroenterology and Hepatology.
Hypertension Puts Young at Risk
Isolated systolic hypertension (ISH) in young and middle-aged adults is on the rise. A study in the Journal of the American College of Cardiology found that ISH puts these patients at higher relative risk for heart disease and mortality than their peers with normal blood pressure. That raises the question of whether these younger ISH patients should be getting drug therapy.
NY Docs Press for E-Script Delay
Handwritten prescriptions will soon be illegal in New York. The Medical Society of the State of New York (MSSNY) and 18 national and NY State medical organizations are trying to delay for a year the onset of a law that would require electonic prescriptions, ban prescription pads, and drastically restrict phoned-in prescriptions. The measure, due to take effect March 27, would require electronic prescriptions for all medications-not just for controlled substances but antibiotics, allergy medications or anything else that requires a prescription.
A commonly used sensitive Troponin detection test to confirm heart attacks is often not being used in a way that will consistently detect these events, a UK research team has found. Writing in the British Medical Journal, Zhivko Zhelev PhD, a diagnostics research fellow at the University of Exeter and colleagues reported on their meta-analysis of studies that assessed the accuracy of a widely used diagnostic test, the Elecsys Troponin T high-sensitivity assay.
The hospital shooting death of Boston cardiac surgeon Michael Davidson, MD, 44, has shocked the cardiology world-far beyond his colleagues at Brigham and Women's Hospital where he was director of endovascular cardiac surgery. On a remembrance page and in formal statements, tributes are pouring in. Davidson, a respected innovator in heart valve replacement, died late Jan. 20, hours after he was shot by the son of a former patient who then turned his gun on himself.He leaves his wife Teri Davidson, who is 7 months pregnant, and 3 children ages 2 to 9.
Older adults hospitalized with pneumonia show an increased risk of cardiovascular disease (CVD) according to a JAMA study. Researchers at the University of Ottawa in Ottawa, Canada looked at the health histories of 5,888 patients enrolled in the Cardiovascular Health Study and 15,792 enrolled in the Atherosclerosis Risk in Communities study. Patients in the first groups were 65 or older and those in the second group were 45 to 65. Of 591 who were hospitalized in the first group, 206 had CVD events within the next decade. In the second group, of 680 hospitalized with pneumonia, 112 had CVD events in the next 10 years.
Slight Blood Pressure Rise Linked to Atrial Fibrillation Risk
An analysis of medical records from 5,311 people indicates that even mildly elevated blood pressure may indicate a dramatically elevated risk of developing atrial fibrillation (AF). Many studies have shown that patients with hypertension - defined as blood pressure above 140/90 mm Hg - are more likely to develop AF than patients with healthy blood pressure, but the new paper may be the first to document a significant association between AF and blood pressure between 120/80 mm Hg and 139/89 mm Hg.
Fasting Blood Glucose and Pancreatic Cancer: Possible Link
January 19th 2015The incidence and mortality of pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States, are both on the rise. Globally, the disease is responsible for 227,000 deaths annually. Researchers from the National Taiwan University College of Medicine recently published a meta-analysis that demonstrated a dose-response relationship between fasting blood glucose levels and pancreatic cancer risk. They also examined the link between prediabetes and pancreatic cancer risk.
Exercise Timing in Patients with Diabetes: Maximizing Metabolic Benefit
January 19th 2015Researchers at the University of Missouri and the National Research Council in Padova, Italy, recently investigated the role that timing of resistance exercise plays in lowering cardiovascular risk. They wondered if the time of day when diabetics exercise could explain the lower-than-expected exercise-derived benefits seen in some diabetics.
Study: Salt Guidelines too Strict
Older people can safely eat just as much salt daily (2300 mg) as younger adults, according to a community-based study reported in JAMAInternal Medicine The current recommendation is 1,500 mg for adults over 50, or a little more than a teaspoon.
Positive Trial Results for Blood Thinner
AstraZeneca announced that its study of ticagrelor (Brilinta) has met its primary efficacy endpoint. In the trial known as Pegasus-TIMI 54, some 21,000 patients taking the tablets twice a day at a dose of either 60 mg or 90 mg plus low-dose aspirin for secondary prevention experienced no unexpected safety issues.